Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Resectable Esophageal Cancer
Both
Resectable Esophageal Cancer
Trial Information
Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer
Inclusion Criteria:
- > 18 years
- resectable esophageal cancer
Exclusion Criteria:
- < 18 years
- esophageal cancer with preoperative distant metastases
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
overall survival
Outcome Time Frame:
2 years
Safety Issue:
Yes
Authority:
Germany: Federal Ministry of Education and Research
Study ID:
CTC-EC
NCT ID:
NCT01858805
Start Date:
April 2010
Completion Date:
April 2013
Related Keywords:
- Resectable Esophageal Cancer
- esophagus carcinoma
- surgery
- circulating tumor cells
- Esophageal Diseases
- Esophageal Neoplasms
- Neoplastic Cells, Circulating
Name | Location |
|---|
